Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZYX | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZUFSP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZSCAN5B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ZSCAN29 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ZSCAN12 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZRANB2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | ZNRF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF92 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF891 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |